Medical Oncology Expert Witnesses

Medical oncology expert witnesses and consultants listed here may be able to form expert opinions, draft expert witness reports, provide expert witness testimony at deposition and/or trial as or serve as consulting (non-testifying) experts on medical oncology. The medical oncology expert witness listings on this page are typically from fields/areas of expertise such as: Correctional Healthcare, Hematology, Internal Medicine, Oncology, and Pharmaceutical Research.

Susan E. Lawrence, MD

Lancaster, California
Correctional Healthcare, Internal Medicine - Medical oncology, prisons, jails, ICE, immigration detention facilities, deliberate indifference, cancer treatment in prison, end of life care in prison, chronic disease management in prison, general inmate health care, correctional medical director, triage, delayed diagnosis, delayed treatment
Experienced Correctional Medicine Physician and Consultant. Double Board Certified (Internal Medicine and Medical Oncology), with additional areas of expertise in HIV/AIDS, viral hepatitis, and coccidioidomycosis. Educated at Barnard College of Columbia University and and Baylor College of Medicine. Founder/former CEO of nonprofit HIV/AIDS organization and and founder of FQHC (Federally Qualified Health Center) for underserved populations. Skilled expert witness with extensive experience in records review, report writing, and deposition/trial testimony. Award winning writer and public speaker. Licensed in California and Indiana. Plaintiff and defense cases accepted. CV upon request.

Glen J Weiss, MD, MBA

Expert Witness: Oncology and Patent Litigation

MiRanostics Consulting, LLC

Boston, Massachusetts
Oncology, Hematology - Medical Oncology, Oncology Drug Development, Hematologic Malignancies, Medical Malpractice, Failure to diagnose cancer, Phase 1-3 Clinical Trials, Immunotherapy, Chemotherapy, Antibodies, Small Molecules, Targeted Therapy, Patent infringement, Indefiniteness, Improper cancer treatment
I am a board-certified medical oncologist with nearly 20 years of experience as a clinical investigator and translational researcher. I bring a deep understanding of oncology drug development and clinical practice. My leadership roles over the past 15 years span community, academic, and research institutions, including serving as faculty at Harvard Medical School. Currently, I am an Affiliate Associate Professor at UMass Chan Medical School and have over five years of experience as a biotech/pharmaceutical medical oncologist. My industry roles include: - Chief Medical Officer for a clinical-stage ADC company. - Chief Medical Officer for a medical technology company developing AI-powered cancer diagnostic tools. - Vice President of Clinical Sciences and medical lead for a CAR-T therapy development company. In these positions, I contributed to business due diligence, investor fundraising presentations, and strategic clinical trial planning. As a clinical investigator, I ha...

Frederick H Hausheer, MD, FACP

Oncology Drug R & D, ICH GCP, Drug Patent Validity

HAUSHEER BIOMED, LLC USA

Austin, Texas
Oncology, Pharmaceutical Research - Oncology Drug Development, Patent Validity, ICH GCP, Written description, Enablement, Obviousness, Anticipation, Pharmacology, FDA, EMA, NMPA/China, PMDA/Japan, Drug formulation, Medical Safety, Phase 1-3 Clinical Trials, Drug Product Safety/Compliance, Medical Oncology
Dr. Frederick (Fred) Hausheer is a physician-scientist with over 37 years of executive leadership and management experience in US and international (EU, JP, China, others) commercial pharmaceutical research and development (Phase I-III), preclinical translational and clinical medicine, clinical pharmacology, ICH GCP compliance and commercial development strategy and risk management of novel cancer therapeutics. His commercial research and development experience includes cytotoxic agents, targeted agents, immuno-oncology therapeutics, cell therapies (BMT, CAR-T), and supportive care medicines. He is an inventor/co-inventor on more than 400 issued United States and international pharmaceutical patents, and author/co-author of more than 200 scientific/medical publications. He is an experienced former CEO and Chief Medical Officer with several biopharma companies and a former NCI-Designated Clinical Investigator, NCI-Institutional Review Board voting member, and NCI-Experimental Ther...